A detailed history of Bollard Group LLC transactions in Haleon PLC stock. As of the latest transaction made, Bollard Group LLC holds 10,000 shares of HLN stock, worth $97,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Previous 10,000 -0.0%
Holding current value
$97,000
Previous $83,000 27.71%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$7.85 - $8.94 $1,899 - $2,163
-242 Reduced 2.36%
10,000 $83,000
Q2 2023

Aug 14, 2023

BUY
$8.04 - $9.0 $1,945 - $2,178
242 Added 2.42%
10,242 $86,000
Q1 2023

May 12, 2023

BUY
$7.57 - $8.37 $75,700 - $83,699
10,000 New
10,000 $81,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Bollard Group LLC Portfolio

Follow Bollard Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bollard Group LLC with notifications on news.